Codagenix Appoints Linda Maldonado as VP, Biologics Chemistry and Manufacturing Controls

FARMINGDALE, N.Y., April 14, 2021 /PRNewswire/ — Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced the appointment of biotech industry veteran Linda Maldonado as Vice President, Biologics Chemistry and…

About the Author

has written 21729 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com